AMN vs VRTX · rev $2.98B vs P/E 30, rev $12.00B
AMN Healthcare Services Inc (AMN) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
AMN Healthcare Services Inc (AMN) is a medical care facilities company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported AMN revenue for 2024-12-31 was $2.98B. Net income was -$147.0M. Revenue was down 21.3% from 2023-12-31 to 2024-12-31. AMN currently screens at market cap $1.23B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
AMN currently screens at market cap $1.23B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the AMN and VRTX stock pages for the full models.
Not investment advice.